Nerve preserving vs standard laparoscopic sacropexy: Postoperative bowel function

Table 2 Symptomatic postoperative findings, anatomical results and late complications in Group A and B patients

No. of patients	Group A 25	Group B 18	P
Follow-up, mo (SD)	19.5 (± 8.4)	17.3 (± 9.8)	0.33
Symptomatic post-operative findings
Persistent vaginal bulge, n (%)	2 (8)	1 (5.5)	> 0.99
De novo stress urinary incontinence, n (%)	0	3 (16.6)	0.07
De novo ODS, n (%)	0	4 (22.2)	0.021
De novo constipation, n (%)	0	0	> 0.99
POPDI-6 (PFDI)a, mean (SD)	4 (± 11.6)	6.8 (± 1.5)	0.5
UDI-6 (PFDI)b, mean (SD)	3.2 (± 5.4)	7.1 (± 1.0)	0.11
CRADI-8 (PFDI)c, mean (SD)	8.3 (± 12.2)	16.9 (± 21.6)	0.1
Agachan-Wexner scored, mean (SD)	3.0 (± 3.0)	6.8 (± 5.2)	0.00
PISQ-12e, mean (SD)	7.6 (3.3)	5.7 (± 2.9)	0.06
Anatomical results, n (%)
Recurrence of vault prolapse	0	1 (5.5)	0.41
Cystocele recurrence/de novo	1 (4)	1 (5.5)	> 0.99
Rectocele recurrence/de novo	0	0	> 0.99
Late complications, n (%)
Erosion	0	1 (5.5)	0.41
Reinterventionf	1 (4)	2 (11.1)	0.56

^aPelvic Organ Prolapse Distress Inventory-6 scores ranged from 0 to 100 with lower scores indicating a better quality of life;

^bUrinary Distress Inventory-6 scores ranged from 0 to 30 with the lower scores indicating a better quality of life;

^cColo-rectal-anal Distress Inventory-8 scores ranged from 0-48, with a higher score indicating a better sexual function;

^dThe Agachan-Wexner score ranges from 0 to 30 with the lower scores indicating a lower bowel dysfunction;

^eThe PISQ-12 score ranges from 0-48 with a higher score indicating a more satisfactory sexual function;

^fAnterior recurrence and mesh erosion; ¹Statistically significant. SD: Standard deviation.